Vanguard Group Inc Relay Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 15,030,209 shares of RLAY stock, worth $58.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,030,209

Previous 14,463,614 3.92%

Holding current value

$58.9 Million

Previous $102 Million 39.53%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$4.12 - $6.8 $2.33 Million - $3.85 Million	566,595 Added 3.92%	15,030,209 $61.9 Million
Q3 2024 Nov 13, 2024	BUY	$6.23 - $9.51 $17.2 Million - $26.2 Million	2,758,748 Added 23.57%	14,463,614 $102 Million
Q2 2024 Aug 13, 2024	SELL	$5.9 - $8.02 $653,737 - $888,640	-110,803 Reduced 0.94%	11,704,866 $76.3 Million
Q1 2024 May 10, 2024	BUY	$7.5 - $12.07 $8.74 Million - $14.1 Million	1,165,282 Added 10.94%	11,815,669 $98.1 Million
Q4 2023 Feb 14, 2024	BUY	$6.01 - $11.48 $589,130 - $1.13 Million	98,025 Added 0.93%	10,650,387 $117 Million
Q3 2023 Nov 14, 2023	BUY	$8.24 - $12.97 $196,070 - $308,621	23,795 Added 0.23%	10,552,362 $88.7 Million
Q2 2023 Aug 14, 2023	BUY	$9.99 - $18.27 $290,239 - $530,798	29,053 Added 0.28%	10,528,567 $132 Million
Q1 2023 May 15, 2023	BUY	$15.0 - $22.76 $1.73 Million - $2.62 Million	115,296 Added 1.11%	10,499,514 $173 Million
Q4 2022 Feb 10, 2023	BUY	$14.16 - $24.02 $28.7 Million - $48.6 Million	2,024,698 Added 24.22%	10,384,218 $155 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $22.8 Million - $39.6 Million	1,261,066 Added 17.77%	8,359,520 $187 Million
Q2 2022 Aug 12, 2022	BUY	$13.31 - $34.88 $11.7 Million - $30.7 Million	880,831 Added 14.17%	7,098,454 $119 Million
Q1 2022 May 13, 2022	BUY	$20.26 - $32.36 $388,607 - $620,697	19,181 Added 0.31%	6,217,623 $186 Million
Q4 2021 Feb 14, 2022	BUY	$26.0 - $37.03 $34.2 Million - $48.7 Million	1,314,405 Added 26.91%	6,198,442 $190 Million
Q3 2021 Nov 12, 2021	BUY	$29.75 - $37.99 $17.6 Million - $22.4 Million	590,595 Added 13.76%	4,884,037 $154 Million
Q2 2021 Aug 13, 2021	BUY	$27.5 - $38.19 $118 Million - $164 Million	4,293,442 New	4,293,442 $157 Million

Others Institutions Holding RLAY

# of Institutions

207

Shares Held

159M

Call Options Held

100K

Put Options Held

26.8K

View Full List

About Relay Therapeutics, Inc.

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $471M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

More about RLAY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Relay Therapeutics, Inc. Transaction History